Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance

Diabetes

Volumn 51, Issue 3, 2002, Pages 624-630

  Franckhauser, Sylvie ^a   Muñoz, Sergio ^a   Pujol, Anna ^a   Casellas, Alba ^a   Riu, Efren ^a   Otaegui, Pedro ^a   Su, Benli ^a   Bosch, Fatima ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; FATTY ACID; GLUCOSE; GLYCEROPHOSPHATE; GLYCOGEN; PHOSPHOPYRUVATE CARBOXYLASE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; CELL SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTERIFICATION; FAT INTAKE; GENE OVEREXPRESSION; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE; STARVATION;

EID: 0036317748     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.3.624     Document Type: Article

References (50)

1. Lipolysis: Contribution from regional fat
2. Phosphoenolpyruvate carboxykinase and the synthesis of glyceride-glycerol from pyruvate in adipose tissue
3. Glyceride-glycerol synthesis from pyruvate
4. Increased adipose tissue glyceroneogenesis in rats adapted to a high protein, carbohydrate-free diet
5. Glyceroneogenesis and the source of glycerol for hepatic triacylglycerol synthesis in humans
6. Regulation of phosphoenolpyruvate carboxykinase (GTP) in adipose tissue in vivo by glucocorticoids and insulin
7. Glucocorticoids control phosphoenolpyruvate carboxykinase gene expression in a tissue specific manner
8. Expression and regulation of cytosolic phosphoenolpyruvate carboxykinase in 3T3-L1 adipocytes
9. Expression of the phosphoenolpyruvate carboxykinase gene in 3T3-F442A adipose cells: Opposite effects of dexamethasone and isoprenaline on transcription
10. Isolation and characterization of the gene coding for cytosolic phosphoenolpyruvate carboxykinase (GTP) from the rat
11. Identification of a fat cell enhancer: Analysis of requirements for adipose tissue-specific gene expression
12. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus
13. The enzymatic carboxylation of phosphoenolpyruvate
14. Correction of diabetic alterations by glucokinase
15. Effect of dietary fat content on the incidence of obesity among ad libitum fed mice
16. Expression of glucokinase in skeletal muscle: A new approach to counteract diabetic hyperglycemia
17. Interrelationship of ketone body metabolism and glucose utilization by adipose tissue in vitro
18. The production and release of glycerol by adipose tissue incubated in vitro
19. Determination of blood sugar
20. A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anesthetized rat
21. Relation between leptin and the regulation of glucose metabolism
22. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
23. A possible physiological role for glyceroneogenesis in rat adipose tissue
24. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression
25. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM
26. Fatty acids, lipotoxicity and insulin secretion
27. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue
28. Transgenic GLUT-4 overexpression in fat enhances glucose metabolism: Preferential effect on fatty acid synthesis
29. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
30. PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes
31. PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene
32. Adipose tissue cellularity in human obesity
33. Monogenic disorders of obesity and body fat distribution
34. Obesity, diabetes, and neoplasia in yellow A vy/- mice: Ectopic expression of the agouti gene
35. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2c receptor gene
36. Impaired glucose tolerance and increased weight gain in transgenic rats overexpressing a non-insulin-responsive phosphoenolpyruvate carboxykinase gene
37. Features of syndrome X develop in transgenic rats expressing a non-insulin responsive phosphoenolpyruvate carboxykinase gene
38. Obesity and insulin resistance
39. Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics
40. Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus
41. Mechanisms of fatty acid-induced inhibition of glucose uptake
42. Protection from induced insulin resistance in mice lacking TNF-α function
43. Generalized lipodystrophy, congenital and acquired (lipoatrophy)
44. Life without fat: A transgenic mouse
45. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
46. Liporegulation in diet-induced obesity: The antisteatotic role of hyperleptinemia
47. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat
48. Preferential channeling of energy fuels toward fat rather than muscle during high free fatty acid availability in rats
49. Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects
50. Plasma levels of tumor necrosis factor-α, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance